drugset
Drugs / Pneumococcal polysaccharide-protein conjugate vaccine
last change Jun 2014 re-read 3 minutes ago

Pneumococcal polysaccharide-protein conjugate vaccine

Vaccine

Developed for
pneumococcal infection
Investigated by
CIPRA SA · National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00099658 · not/applicable
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00099658 Apr 2005 → Dec 2013 HIV infectious disease, pneumococcal infection CIPRA SA Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Pneumococcal polysaccharide-protein conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00099658 ↗
Modality Vaccine “pneumococcal polysaccharide-protein conjugate vaccine (PncCV)” NCT00099658 ↗